CytoDyn Says Its Covid-19 Drug Candidate Reduced Mortality Rate By 82% At 14 Days- Quick Facts

CytoDyn Inc. (CYDY) announced that its Covid-19 drug candidate leronlimab decreased mortality rate by 82% at 14 days in critically ill Covid-19 patients.

Monday the company had reported the publication in the Journal of Translational Autoimmunity "Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab".

Upon further statistical analysis of the critically ill patients with Covid-19, who are receiving invasive mechanical ventilation (IMV) or ECMO, it was found that when leronlimab was added to the standard of care (SoC), mortality rate was decreased by 82% at 14 days, CytoDyn said.

Additionally there was 400% improvement in the ranking on the 7-point ordinal scale at 14 days, after administering leronlimab in conjunction with standard of care (SoC) in the critically ill population.

Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, commented, "We will expediently submit an update with the above 14-day benefit to the U.S. FDA, Health Canada, and MHRA and will work closely with regulators in other countries. The Company believes this new information bolsters the case for immediate use of leronlimab for critically ill patients."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT